14 Best 52-Week High Stocks To Buy According to Analysts

Page 8 of 13

6. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

52 Week Range: $99.06 – $134.17

Current Share Price: $122.96

Stock Upside Potential: 46.09%

Number of Hedge Fund Holders: 40

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a biotechnology company that identifies, develops, and commercializes pharmaceutical products for unmet medical needs. It offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy. It is one of the best 52-week high stocks to buy, according to analysts, as it is making impressive strides in the oncology space.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is working on a promising oncology drug, zanidatamab, as a potential treatment for HER2-resistant cancers. The lead candidate drug has the potential to become a first-line treatment option. If approved, the drug would help strengthen the company’s pipeline, which currently consists of Xywav and Epidiolex/Epidyolex.

Xywav and Epidiolex/Epidyolex are currently driving Jazz Pharmaceuticals plc’s (NASDAQ:JAZZ) top line, having achieved double-digit percentage growth to over $1 billion in sales last year. The company is also pursuing growth opportunities in the cannabis sector, and its sales have increased by 18% in the third quarter to $251 million.

Page 8 of 13